Galectin-3 as a therapeutic target in pulmonary hypertension: Molecular mechanisms, drug development directions, and emerging clinical applications
- DOI
- 10.1016/j.biopha.2025.118756
- Published
- 2025-12
- Container
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.biopha.2025.118756,
title = {Galectin-3 as a therapeutic target in pulmonary hypertension: Molecular mechanisms, drug development directions, and emerging clinical applications},
author = {Antonín Sedlář and Pavla Bojarová and František Kolář and Vladimír Křen and Lucie Bačáková},
year = {2025},
journal = {Biomedicine \& Pharmacotherapy},
doi = {10.1016/j.biopha.2025.118756},
url = {https://doi.org/10.1016/j.biopha.2025.118756}
}RIS
TY - JOUR TI - Galectin-3 as a therapeutic target in pulmonary hypertension: Molecular mechanisms, drug development directions, and emerging clinical applications AU - Antonín Sedlář AU - Pavla Bojarová AU - František Kolář AU - Vladimír Křen AU - Lucie Bačáková PY - 2025 JO - Biomedicine & Pharmacotherapy DO - 10.1016/j.biopha.2025.118756 UR - https://doi.org/10.1016/j.biopha.2025.118756 ER -
APA
Sedlář, A., Bojarová, P., Kolář, F., Křen, V., & Bačáková, L. (2025). Galectin-3 as a therapeutic target in pulmonary hypertension: Molecular mechanisms, drug development directions, and emerging clinical applications. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2025.118756
Source records
- crossref · retrieved 2026-09-26T05:48:40.437Z